CD BioSciences Announces Cytoskeleton-Targeted Tumor Marker Development Service for Cancer Diagnosis
CD BioSciences has announced its cytoskeleton-based tumor marker development service for cancer diagnosis. CD...
CD BioSciences has announced its cytoskeleton-based tumor marker development service for cancer diagnosis. CD...
CD BioSciences has announced its marine drug development services for anticancer therapies, pioneering a new...
For a long time, the research and development of each new drug has faced the...
Nanogels (NGs), namely nanoscale hydrogel particles, are three-dimensional network systems formed by physical or chemical...
Coupling drugs combine the precise targeting and potent killing properties, has become a widely recognized...
BOC Sciences, a globally renowned supplier with over a decade of experience in the biochemical...
Antibody-drug conjugates (ADCs) have emerged as a promising class of treatments in the evolving field of...